SLCO1A2 and prostate cancer: As OATPs have been implicated in both the etiology and treatment of prostate cancer and colon cancer, we undertook to explore whether or not these OATPs are also overexpressed in other tumor types and whether or not OATP expression could serve as a biomarker for tumor development or tumor aggressiveness in certain diseases.